left atrial appendage occlusion (LAAO)

illustration of the human heart focused on the left atrial appendage

March 12, 2024/Heart, Vascular and Thoracic/Cardiac Surgery

Takeaways From Updated STS Guidelines for Surgical Treatment of Atrial Fibrillation

Concomitant AF ablation and LAA occlusion strongly endorsed during elective heart surgery

October 24, 2023/Heart, Vascular and Thoracic/Interventional Cardiology

Concurrent TAVR and Watchman Placement Is Noninferior to TAVR Plus Medical Therapy for Atrial Fibrillation

Randomized WATCH-TAVR trial confirms safety of the combined procedures

illustration of heart and lungs with text

May 4, 2023/Heart, Vascular and Thoracic/Outcomes

Vital Stats From Our Heart Failure and Electrophysiology Programs

Our latest volume and outcomes data in two key subspecialty areas

Boston Scientific Corporation WATCHMAN FLX Device

March 15, 2023/Heart, Vascular and Thoracic/Electrophysiology

Watchman FLX at 1 Year: Real-World Performance Consistent With Trial Results

Large SURPASS registry study confirms high seal rates, acceptable safety

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

March 16, 2022/Heart, Vascular and Thoracic/Electrophysiology

SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days

Interim report from large registry analysis compares favorably with pivotal trial

April 9, 2019/Heart, Vascular and Thoracic/Affiliations & Alliances

Launching an LAAO Program: How Cleveland Clinic Assisted an Affiliated Institution